Forgot Your Password?
Complete Story
 

2006 OPA/OSHP Midyear Meeting

November 5, 2006

Marriott Columbus Airport Hotel, Columbus, Ohio
$$Link
http://www.ohiopharmacists.org/pdf_files/mapwdirections_marriott.pdf
Columbus Airport Marriott map w/driving directions (PDF File 145 KB)
0$$

Because Every Day Counts
The Medicare Part D prescription drug benefit and provisions for Medication Therapy Management (MTM) continue to expand pharmacy practice and the role of the pharmacist in every practice setting. At the same time, these changes are creating new challenges for pharmacists. The 2006 Midyear Meeting will afford pharmacists the information, tools, strategies, and solutions they need to improve patient care. Jointly sponsored by the Ohio Pharmacists Association and the Ohio Society of Health-System Pharmacists, this meeting will provide information to readily implement in a variety of practice settings.

Choose up to eight contact hours (0.8 CEU) of continuing education credit from the 16 hours offered in clinical, management, public health, quality assurance and legislative topics. The programs are educational, practical and interesting, and the faculty is exceptional. Take advantage of this outstanding learning opportunity. Register TODAY! Space is limited.

Registration Fee
OPA or OSHP Member Early Bird - $124
OPA or OSHP Member After 10/13/2006 - $134

Non-member Early Bird - $154
Non-member After 10/13/2006 - $164

Online registration for this event is now closed. On-site registration is available at the event.


SCHEDULE AT A GLANCE
8:00 a.m. Registration and Continental Breakfast

8:30 a.m. Patient Assessment to Improve Outcomes
Marcel Casavant, M.D., FACEP FACMT
Sponsor: Daiichi Sankyo, Inc.

8:30 a.m. Drug Dosing Dilemmas in Chronic Kidney Disease
Mariann Churchwell, PharmD

10:25 a.m. New and Developing Therapeutic Options for Diabetes Management
Nicolette Raya Lindstrom, PharmD
Sponsor: Novo Nordisk Inc.

10:25 a.m. What You Should Know About Vitamin/Mineral Supplements
Laura Poland, R.D., L.D.

12:05 p.m. Lunch

1:10 p.m. Avian Flu: Is it the Next Pandemic?
Panel: Mark Herbert, M.D.; Barbara Bradley, RN, MS; Loren Shaffer; and Carol Elder
Sponsor: Cardinal Health

1:10 p.m. Asthma Update 2006
Jeffrey Weiland, M.D.
Sponsor: AstraZeneca LP

3:05 p.m. Opioid Addiction Pharmacotherapy: Beyond Methadone
Tony Tommasello, Pharmacist, Ph.D.
Sponsor: Reckitt Benckiser Pharmaceuticals, Inc.
(note: this is a 50-minute program)

3:05 p.m. Medicare Part D: A Provider-Oriented Approach
Marc A. Bralts
(note: this is a 50-minute program)

4:05 p.m. Quality Improvement Organizations' Role in Medicare Part D
Bonnie Hollopeter, LPN, CPHQ, CPHIT
(note: this is a 50-minute program)

4:05 p.m. Politics, Legislation and Pharmacy - Know the Facts
Ernest Boyd, R.Ph., CAE and Kelly Vyzral, OPA Lobbyists
(note: this is a 50-minute program)

5:00 p.m. Adjournment

Continuing Education Credit
This meeting is targeted to all pharmacists. Earn up to eight contact hours (0.8 CEU) of continuing pharmacy education credit at a meeting offering 16 hours of educational opportunities from which to choose. The continuing education for this program is coordinated by the Ohio Pharmacists Foundation (OPF). The mission of the Ohio Pharmacists Foundation is to provide educational programs for pharmacists and consumers of health care that enhance the practice of pharmacy and patient outcomes, and to conduct research to support these efforts. The continuing education programs presented by OPF are designed for pharmacists and the public to address the daily issues of pharmacy.

To receive continuing pharmacy education credit, you must fill out the CE form indicating programs attended. Sign, date, and return it to the OPA staff or office. Your statement of CE credit will be mailed to you within four weeks.

$$Link
http://www.ohiopharmacists.org/pdf_files/LearnObj06Midyear
Learning Objectives for Midyear 2006 Continuing Pharmacy Education Programs
0$$

The Ohio Pharmacists Foundation, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.


Hotel Information
The Marriott Columbus Airport Hotel is located at 1375 N. Cassady Avenue in Columbus. Rate: $105 a night. Reservations can be made by calling 614.475.7551 or 800.491.5717. Reservation requests after October 14, 2006 are subject to availability and may not be at the conference rate.


Sponsors To-Date

APSC
AstraZeneca
Cardinal Health
CVS/pharmacy
Daiichi Sankyo
Frank Gates Co.
MemberHealth
McKesson
Novo Nordisk
Pfizer
Reckitt Benckiser



2006 Midyear Program Descriptions

Patient Assessment to Improve Outcomes
Marcel Casavant, M.D., FACEP FACMT
Associate Professor, The Ohio State University
ACPE # 129-000-06-048-L01 0.2 CEU

Medication therapy review, compliance monitoring, and detection of adverse events from medications are especially important for patients with chronic conditions such as diabetes, asthma, hypertension, and congestive heart failure. Pharmacists are often the first to recognize patients' symptoms, and have the opportunity to improve therapeutic outcomes for their patients. Our speaker will discuss common signs and symptoms that these patients may present in the pharmacy, differentiate emergency from non-emergency situations, and suggest appropriate intervention/referral. Sponsor: Daiichi Sankyo, Inc.

Drug Dosing Dilemmas in Chronic Kidney Disease
Mariann Churchwell, PharmD
Assistant Professor
University
of Toledo, College of Pharmacy
ACPE # 129-000-06-049-L01 0.2 CEU
This session will provide a general review of drug dosing in Chronic Kidney Disease (CKD), including changes in adsorption, metabolism, distribution and elimination. Drugs to avoid, use with caution or dose adjust for CKD patients, specifically CKD stages 3-5, will be discussed. This presentation will also include a discussion of OTC drugs, herbal therapies, as well as prescription medications that have the potential to harm a CKD patient.

New and Developing Therapeutic Options for Diabetes Management
Nicolette Raya Lindstrom, PharmD
Assistant Manager
Kroger Pharmacy at Fairfield Medical Center, Lancaster, OH
ACPE # 129-000-06-050-L01 0.2 CEU

This session will introduce and review newly approved agents, as well as those in the pipeline, for the management of diabetes. Agents featured will include the new inhaled insulin, long and rapid acting human insulin analogs, and agents whose mechanisms are based on incretin action, just to name a few. Discover these exciting and optimistic advances made in the fight against diabetes, and learn how these new treatment options may fit into your clinical practice.
Sponsor: Novo Nordisk Inc.

What You Should Know About Vitamin/Mineral Supplements
Laura Poland, R.D., L.D.
Registered Dietitian
The Rite Bite Wellness Center
ACPE # 129-000-06-051-L01 0.2 CEU
Pharmacy shelves are crowded with an overabundance of multiple vitamin/mineral supplements, which makes it difficult to discern one from another. The fact that the first vitamin was discovered less than 100 years ago also brings the realization that our understanding is still quite limited. During this session, we will look at current usage of vitamin/mineral supplements, recommended intake levels, and therapeutic uses for disease management.

Avian Flu: Is it the Next Pandemic?
Mark Herbert, M.D., Infectious Diseases Specialist, Columbus, OH
Barbara Bradley, RN, MS, Chief, Bureau of Infectious Disease Control, Ohio Department of Health
Loren Shaffer, Early Events Surveillance Supervisor, Bureau of Health Surveillance, Ohio Department of Health
Carol Elder, Infection Control Manager, Mount Carmel West Hospital, Columbus, OH
ACPE # 129-000-06-052-L01 0.2 CEU
Worldwide experts believe that another pandemic influenza is inevitable and possibly imminent. Scientists believe that avian viruses played a role in the last three pandemics, and since 1997 unprecedented outbreaks of H5N1 influenza in birds has spread to three continents. Our panel will present the clinical manifestations and control of avian influenza (bird flu); Ohio's pandemic influenza planning efforts coordinated by the Ohio Department of Health; recent legislation outlining the pharmacist's duty to report medication usage changes that might be caused by bioterrorism or certain diseases; and Best Practices of an Ohio hospital in preparing for a pandemic. Time will be allotted for Q&A for this impressive panel of experts.
Sponsor: Cardinal Health

Asthma Update 2006
Jeffrey Weiland, M.D.
Davis Heart & Lung Research Institute
The Ohio State University
ACPE # 129-000-06-053-L01 0.2 CEU
Asthma is a common chronic disease, and pharmacists can have a major impact on managing the disease by working with patients to prevent acute attacks. This program is designed to provide an overview of the pathophysiology of asthma and treatment options, including possible genetic differences in drug response. The rationale behind the selection of a daily controlling agent, and the current controversy regarding the use of beta-2 agonists and other novel inhaled therapy will also be discussed.
Sponsor: AstraZeneca LP

Opioid Addiction Pharmacotherapy: Beyond Methadone
Tony Tommasello, Pharmacist, Ph.D.
Director, Office of Substance Abuse Studies
University of Maryland School of Pharmacy
ACPE # 129-000-06-054-L01 0.1 CEU
Opioid addiction is on the rise due to changes in the market of illicit heroin and increased diversion of prescription opioids. New developments have made it possible to expand effective treatment for opioid addicts. This session will provide an overview of addiction treatment, the pharmacological basis for medical maintenance, and policy changes relative to addiction treatment in the United States.
Sponsor: Reckitt Benckiser Pharmaceuticals, Inc.

Medicare Part D: A Provider-Oriented Approach
Marc A. Bralts, Vice President Business Development
MemberHealth, Inc.
(Community Care Rx Prescription Drug Plan)
ACPE # 129-000-06-055-L04 0.1 CEU
The medication therapy management (MTM) component of Medicare Part D recognizes pharmacists as providers, and at least one organization has designed their prescription drug plan (PDP) around pharmacist-provided MTM and patient interaction. This session will provide background on MTM services and review the provider-oriented approach of the MemberHealth/Community Care Rx PDP, assess results to-date, discuss key metrics on proof-of-concept, and summarize the 2007 Plan Design.

Quality Improvement Organizations' Role in Medicare Part D
Bonnie Hollopeter, LPN, CPHQ, CPHIT
Manager, Physician Office Services
Ohio KePRO
ACPE # 129-000-06-056-L04 0.1 CEU
Quality Improvement Organizations (QIOs) play an important part in protecting the rights and health of Medicare beneficiaries. This program will explain the roles and responsibilities of QIOs, especially as they apply to Medicare Part D. Pharmacy partnerships in a Medicare Part D Long Term Care project of Ohio KePRO, Ohio's Medicare QIO, will also be discussed.

Politics, Legislation and Pharmacy - Know the Facts
Ernest Boyd, R.Ph., CAE and Kelly Vyzral
OPA Lobbyists, Columbus
ACPE # 129-000-06-057-L04 0.1 CEU
The state and federal legislatures are creating opportunities and threats to our profession. This session will update you on the latest political, legislative, and regulatory news, and tell you what to do about it. The profession of pharmacy and its economic position are at risk, and your understanding of issues and action are critical. Medicare Part D, payment for services, immunization changes, and other topics will be covered.
Note: This program is NOT approved for Ohio jurisprudence CE credit.

Special Lunch Presentation in Deshler II-IV: About EXUBERA
An informational session will be presented during lunch for pharmacists who would like to hear about this exciting new addition to treatment options for diabetes patients. This presentation is designed to introduce important information on EXUBERA indications, contraindications, and dosing - critical information you will need to know when counseling your patients on the EXUBERA? Inhaler. About EXUBERA also provides a guide to the EXUBERA? Inhaler, the revolutionary device that delivers EXUBERA, the first insulin inhalation powder approved by the FDA. This training session will demonstrate how to use and maintain the EXUBERA? Inhaler.There is no CE credit awarded for this informational session.
Sponsor: Pfizer, Inc.


< Back | Printer Friendly Page
Get OPA Events via RSS

Events

 October 2014 
SMTWTFS
   1
2
34
56789
1011
121314
15161718
1920212223
2425
262728293031